Skip Page Header

Home > Guidelines for the risk assessment of new synthetic drugs.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Guidelines for the risk assessment of new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

[img]
Preview
PDF (EMCDDA Risk assessment guidelines) - Published Version
168kB

This publication was drawn up by the steering group created by the EMCDDA's Scientific Committee in November 1998 to establish guidelines to assess the risks of all new synthetic drugs identified under the terms of the Joint Action concerning the information exchange, risk assessment and control of new synthetic drugs adopted on 16 June 1997 by the Council of the European Union.

The publication explains the history of the joint action and how it operates, and outlines basic principles, a conceptual framework and quality information for future risk assessments.

Table of contents
• Basic principles for risk assessment
• A conceptual framework for risk assessment
• Quality of information for risk assessment
• Headings for risk assessment
• Pharmacotoxicological evidence
• Psychological risk assessment (cognition, mood and mental functioning)
• Sociological/criminological evidence
• Public health risks: epidemiological evidence


Item Type
Report
Publication Type
International, Guideline
Drug Type
New psychoactive substance
Date
1999
Call No
REF, EMCDDA
Pages
31 p.
Publisher
Office for Official Publications of the European Communities
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
ISBN
92-9168-061-3
EndNote
Accession Number
HRB 4484 (Available), HRB 4485 (Available)
Related (external) link

Repository Staff Only: item control page